Advances in the genetics of progressive myoclonus epilepsy
- 1 June 2001
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (2) , 129-138
- https://doi.org/10.1002/ajmg.1575
Abstract
The genetic progressive myoclonus epilepsies (PMEs) are clinically characterized by the triad of stimulus sensitive myoclonus (segmental lightning like muscular jerks), epilepsy (grand mal and absences) and progressive neurologic deterioration (dementia, ataxia, and various neurologic signs depending on the cause). Etiologically heterogenous, PMEs are rare and mostly autosomal recessive disorders, with the exception of autosomal dominant dentatorubral‐pallidoluysian atrophy and mitochondrial encephalomyopathy with ragged red fibers (MERRF). In the last five years, specific mutations have been defined in Lafora disease (gene for laforin or dual specificity phosphatase in 6q24), Unverricht‐Lundborg disease (cystatin B in 21q22.3), Jansky‐Bielschowsky ceroid lipofuscinoses (CLN2 gene for tripeptidyl peptidase 1 in 11q15), Finnish variant of late infantile ceroid lipofuscinoses (CLN5 gene in 13q21‐32 encodes 407 amino acids with two transmembrane helices of unknown function), juvenile ceroid lipofuscinoses or Batten disease (CLN3 gene in 16p encodes 438 amino acid protein of unknown function), a subtype of Batten disease and infantile ceroid lipofuscinoses of the Haltia‐Santavuori type (both are caused by mutations in palmitoyl‐protein thiosterase gene at 1p32), dentadorubropallidoluysian atrophy (CAG repeats in a gene in 12p13.31) and the mitochondrial syndrome MERRF (tRNA Lys mutation in mitochondrial DNA). In this review, we cover mainly these rapid advances.Keywords
This publication has 44 references indexed in Scilit:
- Regional and Developmental Expression of Epm2a Gene and Its Evolutionary ConservationBiochemical and Biophysical Research Communications, 2001
- Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletionsEuropean Journal of Human Genetics, 2000
- Isolation and Characterization of Mouse Homologue for the Human Epilepsy Gene,EPM2ABiochemical and Biophysical Research Communications, 1999
- A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2)Human Molecular Genetics, 1999
- Lafora Progressive Myoclonus Epilepsy: Narrowing the Chromosome 6q24 Locus by Recombinations and HomozygositiesAmerican Journal of Human Genetics, 1997
- A model for Batten disease protein CLN3: Functional implications from homology and mutationsFEBS Letters, 1996
- Mutations in the Gene Encoding Cystatin B in Progressive Myoclonus Epilepsy (EPM1)Science, 1996
- Construction of a 750-kb bacterial clone contig and restriction map in the region of human chromosome 21 containing the progressive myoclonus epilepsy gene.Genome Research, 1996
- The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6qHuman Molecular Genetics, 1995
- Progressive myoclonus epilepsy: genetic and nosological aspects with special reference to 107 Finnish patientsClinical Genetics, 1979